Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Shares of AppLovin Were Soaring Today (Fool) +++ APPLOVIN Aktie -3,33%

NOVAVAX Aktie

 >NOVAVAX Aktienkurs 
8.98 EUR    +11.4%    (TradegateBSX)
Ask: 8.89 EUR / 3000 Stück
Bid: 8.85 EUR / 3000 Stück
Tagesumsatz: 104280 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
NOVAVAX Aktie über LYNX handeln
>NOVAVAX Performance
1 Woche: +4,9%
1 Monat: +15,8%
3 Monate: -1,3%
6 Monate: +38,7%
1 Jahr: +26,6%
laufendes Jahr: +39,6%
>NOVAVAX Aktie
Name:  NOVAVAX INC. DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US6700024010 / A2PKMZ
Symbol/ Ticker:  NVV1 (Frankfurt)
Kürzel:  FRA:NVV1, ETR:NVV1, NVV1:GR
Index:  -
Webseite:  https://novavax.com/
Profil:  Novavax Inc. is a biotechnology company that engages in the discovery, development, and commercialization of recombinant vaccines to protect against serious infectious diseases. It specializes in protein-based vaccine platforms, including its proprie..
>Volltext..
Marktkapitalisierung:  1305.28 Mio. EUR
Unternehmenswert:  876.12 Mio. EUR
Umsatz:  513.97 Mio. EUR
EBITDA:  51.33 Mio. EUR
Nettogewinn:  -75.7 Mio. EUR
Gewinn je Aktie:  -0.46 EUR
Schulden:  254.3 Mio. EUR
Liquide Mittel:  196.82 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  2.31
Umsatzwachstum:  -55.51%
Gewinnwachstum:  -117.18%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  NOVAVAX
Letzte Datenerhebung:  26.05.26
>NOVAVAX Kennzahlen
Aktien/ Unternehmen:
Aktien: 164.44 Mio. St.
Frei handelbar: 95.08%
Leerverk. Aktien: -
Rückkaufquote: 0.53%
Mitarbeiter: 749
Umsatz/Mitarb.: 1.29 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 55.26%
Bewertung:
KGV: -
KGV lG: -
KUV: 2.52
KBV: -
PEG-Ratio: -
EV/EBITDA: 17.07
Rentabilität:
Bruttomarge: 84.92%
Gewinnmarge: -14.73%
Operative Marge: 6.24%
Managementeffizenz:
Gesamtkaprendite: -7.52%
Eigenkaprendite: -
>NOVAVAX Peer Group
Gesundheit, Impfstoffentwicklung/ Impfstoffhersteller, Covid 19- Behandlung/ post Covid/ long Covid
 
26.05.26 - 16:45
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
 
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....
12.05.26 - 16:45
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know (Zacks)
 
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....
11.05.26 - 16:54
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? (24/7 Wall St.)
 
Shares of Moderna (NASDAQ:MRNA) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35. The intraday move extends what has already been a powerful 2026 run for the mRNA pioneer. The rally is outpacing fellow vaccine names Pfizer (NYSE:PFE), up 2% near $26.10, and Novavax (NASDAQ:NVAX), basically flat ... Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?...
11.05.26 - 16:42
Novavax Stock Is Red Hot but the Smart Money Is Slamming on the Brakes (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.26 - 22:03
Novavax to Participate in BofA Securities 2026 Health Care Conference (PR Newswire)
 
GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference. Conference Details: Fireside Chat Date: Wednesday, May 13, 2026 Time: 3:00 – 3:30 p.m. Pacific Time Location: Las Vegas,......
07.05.26 - 02:48
Novavax (NVAX) Q3 2025 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 22:24
Novavax (NVAX) Q1 2026 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 22:12
Novavax (NVAX) Q2 2025 Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 21:15
Why Novavax Stock Is Trading Higher On Wednesday? (Benzinga)
 
Novavax shares rise after Q1 revenue beat; partnerships, credit facility, and technical levels shape outlook amid shift to net loss. Importance Rank:  2 read more...
06.05.26 - 20:24
Novavax targets $230M-$270M 2026 adjusted revenue while refining 2028 opex to $150M-$200M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 18:18
Novavax übertrifft Prognosen für Q1 2026 – Aktie legt deutlich zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.05.26 - 16:45
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates (Zacks)
 
Novavax (NVAX) delivered earnings and revenue surprises of +75.68% and +100.70%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...
05.05.26 - 17:57
Novavax Q1 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.05.26 - 17:30
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates? (Zacks)
 
ANI Pharmaceuticals, Novavax and three other biotechs show strong Earnings ESP signals, hinting at potential Q1 earnings beat as sector results roll in....
02.05.26 - 01:00
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
 
Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close....
29.04.26 - 22:01
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 (PR Newswire)
 
GAITHERSBURG, Md., April 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Wednesday, May 6, 2026. Details of the event and replay are as follows:......
24.04.26 - 01:00
Novavax (NVAX) Dips More Than Broader Market: What You Should Know (Zacks)
 
In the closing of the recent trading day, Novavax (NVAX) stood at $8.15, denoting a -3.55% move from the preceding trading day....
18.04.26 - 01:00
Novavax (NVAX) Outperforms Broader Market: What You Need to Know (Zacks)
 
Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close....
13.04.26 - 16:45
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
 
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store....
10.04.26 - 01:00
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
 
In the latest trading session, Novavax (NVAX) closed at $8.53, marking a +1.31% move from the previous day....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wer am meisten weiß, glaubt am wenigsten. - Sprichwort Italien
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!